Clinical Trial: Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults

U.S., Oct. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07215520) titled 'Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults' on Oct. 01.

Brief Summary: A Double-blind, Randomized, Controlled, Phase 2a Study to Evaluate the Safety and Tolerability of a Newcastle Disease Virus-based Mucosal Vaccine (NDV-HXP-S-KP.2) Relative to an Approved Systemic mRNA Vaccine in Previously Vaccinated Adults

Study Start Date: Oct. 20

Study Type: INTERVENTIONAL

Condition: COVID-19

Intervention: BIOLOGICAL: NDV-HXP-S-KP.2

Nasal Administration of a COVID-19 vaccine to compare against a commercially available mRNA vaccine

BIOLOGICAL: COVID-19 mRNA Vaccine...